Investigator Site 022 — Columbus, Ohio

Investigator Site 022 is a clinical research site located in Columbus, Ohio, United States 43210.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site 022 has participated in 1 clinical trials.

Therapeutic areas: Hyperkalemia, Heart Failure.

Sponsors: Relypsa, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 022?

Investigator Site 022 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 022 conducted?

Investigator Site 022 has 1 clinical trials on record. Their work covers Hyperkalemia, Heart Failure.

Is Investigator Site 022 accredited by Crixeo Health?

Investigator Site 022 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 022?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.